Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A novel selective stabilizer of the ryanodine receptor 2 prevents stress-induced ventricular arrhythmias without impairing cardiac function.

British journal of pharmacology·2026
Same author

Efficacy and safety of peptide radionuclide therapy with <sup>177</sup>Lu-DOTATATE in Japanese patients with advanced neuroendocrine neoplasm: a multicenter retrospective study (JON2203-N).

Journal of gastroenterology·2026
Same author

Comparison of chemoradiotherapy and gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer: an integrated analysis of two randomized phase II trials (JCOG2408A).

BMC cancer·2026
Same author

Sepsis-associated skeletal muscle wasting is ameliorated by pharmacological inhibition of the STAT3 signaling pathway in mice.

Scientific reports·2026
Same author

Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
Same author

Smart Life-Space Surveillance: Integrated Life-Space Mobility Monitoring Using a Sensor Fusion System for Older Adults Living Alone.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025

相关实验视频

Updated: Jul 1, 2025

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
08:47

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes

Published on: December 16, 2022

2.4K

[使用人类iPS细胞衍生的心肌细胞来评估收缩功能]

Junko Kurokawa1, Satoshi Shimizu1, Kazuho Sakamoto1

  • 1Department of Bio-informational Pharmacology, Faculty of Pharmaceutical Sciences, University of Shizuoka.

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
|March 3, 2024
PubMed
概括

使用人类诱导的多能干细胞干细胞衍生的心肌细胞 (hiPSC-CMs) 预测抗癌药物心脏毒性显示出希望. 优化用于评估hiPSC-CM收缩功能的实验系统对于患者特异性毒性预测至关重要.

科学领域:

  • 生物医学科学 生物医学科学
  • 心脏病学 心脏病学
  • 药物开发 药物开发

背景情况:

  • 抗癌药物可以引起心脏毒性,导致心力衰竭.
  • 患者背景和药物类型/剂量影响心脏毒性风险.
  • 人类诱导的多能干细胞衍生心肌细胞 (hiPSC-CMs) 为患者特异性毒性预测提供了潜力.

研究的目的:

  • 审查心脏收缩机制.
  • 引入一种用于测量心脏细胞收缩的新方法.
  • 讨论目前使用hiPSC-CMs进行心脏毒性评估的收缩功能评估方法.

主要方法:

  • 心脏细胞收缩机制的概述.
  • 开发和引入一种新的收缩测量技术.
  • 审查现有的基于hiPSC-CM的收缩功能评估系统.

主要成果:

  • 抗癌药物的心脏毒性是一个重要的临床问题.
  • hiPSC-CMs为预测患者特异性药物毒性提供了一个可行的模型.
  • 在优化基于hiPSC-CM的功能评估实验系统方面仍然存在挑战.

结论:

关键词:
抗癌药物 抗癌药物是一种抗癌药物.收缩的功能 收缩的功能心脏衰竭是因为心脏衰竭.诱导多能干细胞 (iPS) 诱导多能干细胞肌细胞细胞质细胞.

更多相关视频

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
05:06

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes

Published on: May 5, 2020

13.1K
Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
08:03

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

Published on: October 20, 2022

1.8K

相关实验视频

Last Updated: Jul 1, 2025

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
08:47

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes

Published on: December 16, 2022

2.4K
Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
05:06

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes

Published on: May 5, 2020

13.1K
Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
08:03

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

Published on: October 20, 2022

1.8K
  • 准确预测抗癌药物诱导的心脏毒性是必不可少的.
  • 在hiPSC-CM技术的进步是改善预测模型的关键.
  • 为了临床应用,需要进一步开发功能评估系统.